CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation
Yao, Mingfei1; Lu, Yanmeng1; Zhang, Ting2; Xie, Jiaojiao1; Han, Shengyi1; Zhang, Shuobo1; Fei, Yiqiu1; Ling, Zongxin1; Wu, Jingjing1; Hu, Yue3
刊名NPJ BIOFILMS AND MICROBIOMES
2021-07-09
卷号7期号:1页码:10
DOI10.1038/s41522-021-00228-1
通讯作者Li, Lanjuan(ljli@zju.edu.cn)
英文摘要The low viability during gastrointestinal transit and poor mucoadhesion considerably limits the effectiveness of Ligilactobacillus salivarius Li01 (Li01) in regulating gut microbiota and alleviating inflammatory bowel disease (IBD). In this study, a delivery system was designed through layer-by-layer (LbL) encapsulating a single Li01cell with chitosan and alginate. The layers were strengthened by cross-linking to form a firm and mucoadhesive shell (similar to 10 nm thickness) covering the bacterial cell. The LbL Li01 displayed improved viability under simulated gastrointestinal conditions and mucoadhesive function. Almost no cells could be detected among the free Li01 after 2 h incubation in digestive fluids, while for LbL Li01, the total reduction was around 3 log CFU/mL and the viable number of cells remained above 6 log CFU/mL. Besides, a 5-fold increase in the value of rupture length and a two-fold increase in the number of peaks were found in the (bacteria-mucin) adhesion curves of LbL Li01, compared to those of free Li01. Oral administration with LbL Li01 on colitis mice facilitated intestinal barrier recovery and restoration of the gut microbiota. The improved functionality of Li01 by LbL encapsulation could increase the potential for the probiotic to be used in clinical applications to treat IBD; this should be explored in future studies.
资助项目National Key Research and Development Program of China[2018YFC2000500] ; National Natural Science Foundation of China[32001683] ; Beijing Advanced Innovation Center for Food Nutrition and Human Health ; National Science Foundation of China[81790631]
WOS关键词IN-VITRO ; GUT MICROBIOTA ; PROBIOTICS ; DELIVERY ; POLYSACCHARIDES ; VISCOSITY ; PROTEINS ; BACTERIA ; ADHESION ; COLITIS
WOS研究方向Biotechnology & Applied Microbiology ; Microbiology
语种英语
出版者NATURE RESEARCH
WOS记录号WOS:000674446800001
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/296744]  
专题中国科学院上海药物研究所
通讯作者Li, Lanjuan
作者单位1.Zhejiang Univ, Natl Clin Res Ctr Infect Dis,Affiliated Hosp 1, Coll Med,State Key Lab Diag & Treatment Infect Di, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Peoples R China
2.Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Bone Marrow, Hangzhou, Peoples R China
3.Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Peoples R China
4.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Mol Imaging Res, Shanghai, Peoples R China
5.Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden
推荐引用方式
GB/T 7714
Yao, Mingfei,Lu, Yanmeng,Zhang, Ting,et al. Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation[J]. NPJ BIOFILMS AND MICROBIOMES,2021,7(1):10.
APA Yao, Mingfei.,Lu, Yanmeng.,Zhang, Ting.,Xie, Jiaojiao.,Han, Shengyi.,...&Li, Lanjuan.(2021).Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation.NPJ BIOFILMS AND MICROBIOMES,7(1),10.
MLA Yao, Mingfei,et al."Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation".NPJ BIOFILMS AND MICROBIOMES 7.1(2021):10.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace